TRPMA

COVID-19 Pandemic Control Industry

Diagnostics

Latest Events All Events

TRPMA | 2020/05/20

TRPMA MEDX Club 創新醫療器材成立之夜

Learn more

None | 2019/12/09

FBRI X TRPMA Special Seminar- Commercialization Considerations of Cell Therapy Products

Learn more

TRPMA | 2019/11/08

Emerging Biomarkers for Immune Checkpoint Blockade: Challenges and Opportunities

Learn more

Latest News All News

Date Posted	News Title
2021/04/14	US: Insurance, physician barriers impede wider adoption of biosimilars
2021/04/13	Asia: Vietnam MOH implements online system to maintain validity of drug licences
2021/04/12	ATMPs: Global regulators eye harmonization for ultra-orphan products
2021/04/09	COVID 19: EMA finds possible link of AZ vaccine to very rare cases of unusual blood clots with low blood platelets
2021/04/08	Europe: UK MHRA advice on responding to GLP and GCP inspection reports

Date Posted	News Title
2021/04/07	Europe: MoU facilitates health innovation and medical societies collaboration
2021/04/06	US: FDA offers guidance on generic drug development during COVID
2021/04/05	Europe: Digital healthcare in UK primary care
2021/04/02	Europe: European Commission kicks off review of pharmaceutical legislation
2021/04/01	Australia: TGA published regulatory changes for software based medical devices

Orient EuroPharma Co., Ltd.

Taiwan Global Biofund (TGB)

YFY Biotech Management Company

Orient PHARMA Co., Ltd.

TaiGen Biotechnology Co., Ltd.

TaiRx, Inc.

OBI Pharma, Inc.

Taiwan Liposome Company, Ltd.

Mycenax Biotech Inc.

TWi Biotechnology, Inc

SynCore Biotechnology Co., Ltd.

TCM Biotech International Corp.

Medigen Biotechnology Corp.

Eusol Biotech Co., Ltd.

PharmaEssentia Corporation

Excelsior Biopharma Inc.

SyneuRx International (Taiwan) Corp.

Taiwan Advance Bio-Pharmaceutical Inc.

Center Laboratories, Inc.

Taiwan Bio Therapeutics Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.

Development Center for Biotechnology

Lumosa Therapeutics Co., Ltd.

Steminent Biotherapeutics Inc.

SinoCell Technologies

UnicoCell Biomed Co., Ltd.

Ever Supreme Bio Technology Co., Ltd.

Medigen Vaccine Biologics Corp.

Gwo Xi Stem Cell Applied Technology Co., Ltd.

Three-Power Tech. Co., Ltd.

Kartigen Biomedical Inc.

Lukas Biomedical Inc.

Maria Von Med-Biotechnology Co., Ltd.

Schweitzer Biotech Company Ltd.

Hasumi International Co., Ltd.

Vectorite Biomedical Inc.

MiCareo Taiwan Co., Ltd

EirGenix INC.

ACT Genomics

EMO BIOMEDICINE CORP.

ARCE Therapeutics, Inc.

Somnics, Inc.

Apollo Medical Optics, Ltd.

Brain Navi Biotechnology Co., Ltd.

iXensor

Raypal Biomedical Co., Ltd.

Heroic Faith Medical Science Co., Ltd.

Advagene Biopharma Co., Ltd.

BioIPSeeds

Biomaterial One-Stop-Shop Website

Biopharmaceutical Analyst Program (BAP)

Rising Star - Taiwan New Drug

Overview of R&D of Taiwan’s Regenerative Medicine Industries (in Chinese))

Presentation Slides of “Regenerative Medicinal Products Derivatives Act” Hearing (in Chinese)

Join Us

We welcome companies engaged in the development of new drugs, biologics, regenerative medicinal products and emerging pharmaceutical products to join us in establishing a robust industrial value chain, promoting the biotech new drug industry in Taiwan, and becoming key players in the global markets.
Details